NOVAVAX INC: cash_and_equivalents
| Value | {"amount": 568505000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:04.438994+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9a03ac7e-7a8b-414e-874b-7d7a534bf21c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001000694-24-000007Retrieved: 2026-08-19T09:41:04.438994+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/cash-and-equivalents/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9a03ac7e-7a8b-414e-874b-7d7a534bf21c
History
- no predecessors — first report